ProQR Therapeutics (PRQR) Dividends Paid - Common Growth (3y) (2016 - 2025)
ProQR Therapeutics (PRQR) Dividends Paid - Common Growth (3y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.26% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | ProQR Therapeutics | 206.80 Mn | 111.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 7.26% |
| Mar 31, 2025 | -9.53% |
| Sep 30, 2024 | -18.91% |
| Jun 30, 2024 | -20.29% |
| Mar 31, 2024 | 4.38% |
| Sep 30, 2023 | 8.14% |
| Jun 30, 2023 | 13.41% |
| Mar 31, 2023 | 1,012.81% |
| Sep 30, 2022 | 6.76% |
| Jun 30, 2022 | 21.67% |
| Mar 31, 2022 | 20.72% |
| Dec 31, 2021 | 1,111.95% |
| Sep 30, 2021 | 11.66% |
| Jun 30, 2021 | 62.21% |
| Mar 31, 2021 | 11,959.42% |
| Dec 31, 2020 | 1,068.78% |
| Sep 30, 2020 | 12,949.72% |
| Jun 30, 2020 | 27.29% |
| Mar 31, 2020 | 24.93% |
| Dec 31, 2019 | 24.74% |